当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析 - 现金流量表

微芯生物

(688321)

  

流通市值:116.47亿  总市值:116.47亿
流通股本:4.08亿   总股本:4.08亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金600,839,571.42398,607,546.28202,877,425.47724,164,341.79
  收到的税费返还---1,422.66
  收到其他与经营活动有关的现金36,992,053.5134,576,857.5611,329,491.5223,826,097.22
  经营活动现金流入小计637,831,624.93433,184,403.84214,206,916.99747,991,861.67
  购买商品、接受劳务支付的现金48,540,672.8730,769,935.7621,578,487.3832,867,832.51
  支付给职工以及为职工支付的现金246,368,451.96175,579,202.94104,212,598.19306,637,659.62
  支付的各项税费30,129,889.3715,218,658.254,774,438.9127,682,866.7
  支付其他与经营活动有关的现金252,870,535.95149,558,109.3763,661,544.22304,675,225.53
  经营活动现金流出小计577,909,550.15371,125,906.32194,227,068.7671,863,584.36
  经营活动产生的现金流量净额59,922,074.7862,058,497.5219,979,848.2976,128,277.31
二、投资活动产生的现金流量:
  收回投资收到的现金1,101,320,011.15690,883,550.34287,592,095.641,363,159,077.38
  取得投资收益收到的现金9,530,779.855,148,176.92,573,109.4512,920,581.93
  处置固定资产、无形资产和其他长期资产收回的现金净额13,772.789,640.054,556.073,743.26
  投资活动现金流入小计1,110,864,563.78696,041,367.29290,169,761.161,376,083,402.57
  购建固定资产、无形资产和其他长期资产支付的现金114,938,351.1653,208,351.1217,436,780.09268,487,363.15
  投资支付的现金1,144,869,696.66692,756,636.68329,844,4421,403,630,203.1
  投资活动现金流出小计1,259,808,047.82745,964,987.8347,281,222.091,672,117,566.25
  投资活动产生的现金流量净额-148,943,484.04-49,923,620.51-57,111,460.93-296,034,163.68
三、筹资活动产生的现金流量:
  取得借款收到的现金401,885,265197,000,000125,000,000408,185,670
  筹资活动现金流入小计401,885,265197,000,000125,000,000408,185,670
  偿还债务支付的现金208,970,280.0187,398,743.3458,707,206.67186,359,896.68
  分配股利、利润或偿付利息支付的现金25,439,063.5612,686,146.866,609,384.127,628,241.13
  支付其他与筹资活动有关的现金3,502,845.312,225,939.971,121,050.3718,834,709.38
  筹资活动现金流出小计237,912,188.88102,310,830.1766,437,641.14232,822,847.19
  筹资活动产生的现金流量净额163,973,076.1294,689,169.8358,562,358.86175,362,822.81
四、汇率变动对现金及现金等价物的影响-1,729,409.36-77,413.06-143,302.02394,133.86
五、现金及现金等价物净增加额73,222,257.5106,746,633.7821,287,444.2-44,148,929.7
  加:期初现金及现金等价物余额222,540,408.86222,540,408.86222,540,408.86266,689,338.56
  期末现金及现金等价物余额295,762,666.36329,287,042.64243,827,853.06222,540,408.86
补充资料:
  净利润-29,592,228.83--114,570,600.33
  资产减值准备---90,066,807.59
  固定资产和投资性房地产折旧-18,118,834.39-31,566,392.29
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-18,118,834.39-31,566,392.29
  无形资产摊销-15,490,652.34-25,082,317.09
  长期待摊费用摊销-1,514,295-2,462,663.39
  处置固定资产、无形资产和其他长期资产的损失-10,585.9--234.5
  固定资产报废损失-40,310.14-53,213.93
  公允价值变动损失----106,925
  财务费用-9,683,864.89-17,729,777.63
  投资损失-10,753,345.71-21,707,957.3
  递延所得税--1,806,179.79-16,065,729.08
  其中:递延所得税资产减少-5,476.17-550,458.73
    递延所得税负债增加--1,811,655.96-15,515,270.35
  存货的减少--13,773,112.15-6,285,636.69
  经营性应收项目的减少--75,787,772.11--19,617,273.32
  经营性应付项目的增加-67,813,337.48-3,075,263.5
  其他--935,513.86--3,370,424.87
  现金的期末余额-329,287,042.64-222,540,408.86
  减:现金的期初余额-222,540,408.86-266,689,338.56
  现金及现金等价物的净增加额-106,746,633.78--44,148,929.7
公告日期2025-10-312025-08-262025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑